EGFR and ovarian carcinoma: However, Gershenson et al. concluded that immunostaining for p53, epidermal growth factor receptor, HER-2/neu, DNA ploidy, and S-phase fraction did not distinguish TCC from other common epithelial ovarian cancers[6,7].